Cargando…

Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms

Detalles Bibliográficos
Autores principales:	Pain, Clare E, Felsenstein, Susanna, Cleary, Gavin, Mayell, Sarah, Conrad, Karsten, Harave, Srikrishna, Duong, Phuoc, Sinha, Ian, Porter, David, Hedrich, Christian M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228732/ https://www.ncbi.nlm.nih.gov/pubmed/32427161 http://dx.doi.org/10.1016/S2665-9913(20)30137-5

Ejemplares similares

COVID-19 in children and young people
por: Felsenstein, Susanna, et al.
Publicado: (2020)

COVID-19 cytokine storm: targeting the appropriate cytokine
por: Cron, Randy Q
Publicado: (2021)

Presentation, Treatment Response and Short-Term Outcomes in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS)
por: Felsenstein, Susanna, et al.
Publicado: (2020)

Can tocilizumab calm the cytokine storm of COVID-19?
por: Schulert, Grant S
Publicado: (2020)

No perfect therapy for the imperfect COVID-19 cytokine storm
por: Cron, Randy Q
Publicado: (2022)

Cytokine adsorption during ECMO for COVID-19-related ARDS
por: Shekar, Kiran, et al.
Publicado: (2021)

COVID-19 cytokine storm syndrome: a threshold concept
por: Chen, Luke Y C, et al.
Publicado: (2021)

GM-CSF in the treatment of COVID-19: a new conductor in the pathogenesis of cytokine storm?
por: Favalli, Ennio Giulio, et al.
Publicado: (2020)

Intravenous immunoglobulin therapy for COVID-19 ARDS
por: Wilfong, Erin M, et al.
Publicado: (2022)

β-agonists for ARDS: the dark side of adrenergic stimulation?
por: Thompson, B Taylor
Publicado: (2012)

SARS-CoV-2 infections in children and young people
por: Felsenstein, Susanna, et al.
Publicado: (2020)

Arglabin could target inflammasome-induced ARDS and cytokine storm associated with COVID-19
por: Manayi, Azadeh, et al.
Publicado: (2021)

A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System
por: Zhang, Yimin, et al.
Publicado: (2021)

Higher PEEP in intubated COVID-19-associated ARDS patients? We are not sure
por: Yaroshetskiy, Andrey I., et al.
Publicado: (2022)

The Imperfect Cytokine Storm: Severe COVID-19 With ARDS in a Patient on Durable LVAD Support
por: Chau, Vinh Q., et al.
Publicado: (2020)

We need to bring R0 < 1 to treat cancer too
por: Srikrishna, Devabhaktuni, et al.
Publicado: (2021)

COVID-19-related ARDS: one disease, two trajectories, and several unanswered questions
por: Lascarrou, Jean-Baptiste
Publicado: (2021)

Why compliance and driving pressure may be inappropriate targets for PEEP setting during ARDS
por: Grieco, Domenico Luca, et al.
Publicado: (2022)

COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and is modified by dexamethasone
por: Sarma, Aartik, et al.
Publicado: (2021)

Accelerating measles elimination in the Western Pacific Region during the calm between the storms
por: Durrheim, David N., et al.
Publicado: (2022)

Time-controlled adaptive ventilation in patients with ARDS—lack of protocol adherence: a systematic review
por: Katzenschlager, Stephan, et al.
Publicado: (2023)

Paediatric virology and medical terminology
por: Mammas, Ioannis N., et al.
Publicado: (2020)

Conquering the cytokine storm in COVID‐19‐induced ARDS using placenta‐derived decidua stromal cells
por: Sadeghi, Behnam, et al.
Publicado: (2021)

Conquering the Cytokine Storm in COVID-19 Induced ARDS Using Placenta-Derived Decidua Stromal Cells
por: Ringden, Olle, et al.
Publicado: (2022)

ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?
por: Shekar, Kiran, et al.
Publicado: (2020)

Further validation of the efficacy of mesenchymal stem cell infusions for reducing mortality in COVID-19 patients with ARDS
por: Shetty, Ashok K., et al.
Publicado: (2021)

Paediatric patient stratification in the emergency department
por: Balamuth, Fran, et al.
Publicado: (2020)

Tumour-agnostic drugs in paediatric cancers
por: Chisholm, Julia C., et al.
Publicado: (2020)

Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era
por: Gandini, Lucia, et al.
Publicado: (2023)

The future of paediatric acute respiratory distress syndrome
por: Carlton, Erin F, et al.
Publicado: (2023)

Reply to: Microbial Burden-associated Cytokine Storm May Explain Non-Resolving ARDS in COVID-19 Patients
por: Kullberg, Robert F. J., et al.
Publicado: (2022)

Cytokine Storm
por: Fajgenbaum, David C., et al.
Publicado: (2020)

COVID-19 threat and frontline paediatric care professionals
por: Koutsaftiki, Chryssie, et al.
Publicado: (2020)

Viruses, vaccinations and RSV: Exploring terminology in paediatric virology
por: Mammas, Ioannis N., et al.
Publicado: (2020)

A multidisciplinary approach to paediatric and adolescent metabolic health
por: Anane, Derek, et al.
Publicado: (2022)

Reports to the UK Yellow Card Scheme 2000-2009 for medications used in paediatric rheumatology
por: Hawcutt, Daniel B, et al.
Publicado: (2011)

Addressing the global burden of paediatric critical COVID-19 and mortality
por: Kamidani, Satoshi, et al.
Publicado: (2022)

Paediatric out-of-hospital cardiac arrest: Time to update registries?
por: Katzenschlager, Stephan, et al.
Publicado: (2023)

Selective Impact of Selenium Compounds on Two Cytokine Storm Players
por: Sinha, Indu, et al.
Publicado: (2023)

Strategic plan for management of COVID-19 in paediatric haematology and oncology departments
por: He, Yulei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oe14bco1u0a7o5cd9enb6kjsc8